Your Health, We Care
Release date: 2024-08-13 09:45:39 Recommended: 152
Pemigatinib is used in adults to treat bile duct cancer that has spread to other parts of the body (metastatic) or cannot be removed with surgery. Pemigatinib is usually given after your cancer has been treated with another medicine.
The price of Pemigatinib varies greatly depending on the size and source.
At present, the most widely circulated in the market is Pemigatinib 4.5mg*14 tablets produced by Lucius Pharmaceutical Co., Ltd., with a price of 1400 yuan.
Patients and their families should pay attention to choosing qualified hospitals, pharmacies, or officially certified online pharmacies when purchasing, and avoid purchasing from informal channels or private hands, so as to prevent the purchase of counterfeit and shoddy products. At the same time, pay attention to verifying drug information, and check key information such as approval number, production date, and expiration date on the drug packaging to ensure that the drug has not expired and meets national regulations.
As an innovative drug, the research and development process of Pemigatinib requires a lot of investment in money and time. There are costs associated with the production of pharmaceutical products. These costs have a direct impact on the final selling price of the drug.
The number of patients, the demand for treatment, and the efficacy and safety of the drug can all affect the market demand, which in turn affects the price. The availability of a drug can also affect its price. If the supply is insufficient, the price may rise; And if there is an oversupply, the price may fall.
Original drugs refer to original new drugs, which are independently researched developed, and produced by enterprises with drug patent rights. Generic drugs are drugs that are imitated by other companies after the expiration of the patent protection period of the original drug based on the research of the main components of the original drug.
The R&D process of an innovator drug usually requires a long period of safety evaluation and complete clinical trials, and its R&D cycle is long, generally up to 15 years, and the R&D investment is huge, often requiring billions of dollars or even more funds. The research and development of generic drugs is relatively simple, one only needs to explore the composition and synthesis method of the original drug, and after a simple clinical trial, it can be produced and marketed after passing the relevant inspection standards. Its development time is relatively short, generally only 10 to 13 months.
The original drug has undergone a complete and rigorous phase III clinical trial, including its use in a large number of patients and populations, and its safety and efficacy have been fully verified. Although generic drugs also need to conduct clinical trials before they are marketed, the scale and scope of these trials are relatively small, and they lack the large-scale, long-term clinical data accumulation of the original drug. After the product is launched, many innovator companies will also conduct phase IV clinical trials to verify its post-marketing safety and follow-up.
【Warm tips】When patients buy generic drugs, they should choose formal channels to ensure the quality and safety of the drugs. Avoid purchasing counterfeit products from informal sources.
